|
proctolin receptor activity
|
GO_0035236 |
[Combining with the neuropeptide proctolin, to initiate a change in cell activity.] |
|
endocardium formation
|
GO_0060214 |
[Formation of the endocardium of the heart. The endocardium is an anatomical structure comprised of an endothelium and an extracellular matrix that forms the innermost layer of tissue of the heart, and lines the heart chambers.] |
|
corazonin receptor activity
|
GO_0035237 |
[Combining with the neuropeptide corazonin to initiate a change in cell activity.] |
|
primitive hemopoiesis
|
GO_0060215 |
[A first transient wave of blood cell production that, in vertebrates, gives rise to erythrocytes (red blood cells) and myeloid cells.] |
|
embryonic hemopoiesis
|
GO_0035162 |
[The stages of blood cell formation that take place within the embryo.] |
|
cognition
|
GO_0050890 |
[The operation of the mind by which an organism becomes aware of objects of thought or perception; it includes the mental activities associated with thinking, learning, and memory.] |
|
multicellular organismal-level water homeostasis
|
GO_0050891 |
[A chemical homeostatic process involved in the maintenance of a steady state level of water within extracellular body fluids, such as blood, xylem or phloem, of a multicellular organism. This is distinct from maintenance of cellular homeostasis, which occurs within a cell.] |
|
hematopoietic stem cell differentiation
|
GO_0060218 |
[The process in which a relatively unspecialized cell acquires specialized features of a hematopoietic stem cell. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.] |
|
hematopoietic progenitor cell differentiation
|
GO_0002244 |
[The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell, a class of cell types including myeloid progenitor cells and lymphoid progenitor cells.] |
|
intestinal absorption
|
GO_0050892 |
[A process in which nutrients are taken up from the contents of the intestine.] |
|
camera-type eye photoreceptor cell differentiation
|
GO_0060219 |
[The process in which a relatively unspecialized cell acquires the specialized features of a photoreceptor cell in a camera-type eye.] |
|
eye photoreceptor cell differentiation
|
GO_0001754 |
[The process in which a relatively unspecialized cell acquires the specialized features of a photoreceptor cell, as found in the eye, the primary visual organ of most organisms.] |
|
cytoneme
|
GO_0035230 |
[A long, thin, polarized cell projection that contains actin and can extend for distances many times the diameter of the cell. Cytonemes represent extensions of cell cytoplasm and typically have a diameter of approximately 0.2um.] |
|
regulation of systemic arterial blood pressure by chemoreceptor signaling
|
GO_0001979 |
[The process that modulates blood pressure by the action of chemoreceptors found in the carotid and aortic bodies and their resultant modulation of the vasomotor center. Chemoreceptors respond to oxygen, carbon dioxide and hydrogen ions.] |
|
cytoneme assembly
|
GO_0035231 |
[Formation of a cytoneme, a long, thin and polarized actin-based cytoplasmic extension that projects from a cell.] |
|
renal system process involved in regulation of blood volume
|
GO_0001977 |
[A slow mechanism of blood pressure regulation that responds to changes in pressure resulting from fluid and salt intake by modulating the quantity of blood in the circulatory system.] |
|
blood vessel remodeling
|
GO_0001974 |
[The reorganization or renovation of existing blood vessels.] |
|
cobalt ion binding
|
GO_0050897 |
[Binding to a cobalt ion (Co2+).] |
|
response to amphetamine
|
GO_0001975 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amphetamine stimulus. Amphetamines consist of a group of compounds related to alpha-methylphenethylamine.] |
|
retinoic acid binding
|
GO_0001972 |
[Binding to retinoic acid, 3,7-dimethyl-9-(2,6,-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid.] |